LeMaitre Vascular stock holds at USD 79.13 as valuation draws scrutiny

Published on 09/22/2026 at 23:13 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

LeMaitre Vascular stock traded at USD 79.13 on September 22, 2026, while its market value reached USD 1.81 billion. The stock's forward P/E stood at 25.8.

LMAT, US52567J1079, Illustration mit AI erstellt.

LeMaitre Vascular Inc. (ISIN US52567J1079) was quoted at USD 79.13 on September 22, 2026, while its market capitalization stood at USD 1.81 billion. The valuation is the central market fact for LMAT stock, with a forward price-to-earnings ratio of 25.8 reported for the same date.

Valuation carries the story

According to StockStory on September 22, 2026, LeMaitre develops specialized medical devices for vascular surgeons treating peripheral vascular disease and other circulatory conditions. The same report placed the company at USD 79.13 and cited a forward P/E of 25.8, making the multiple a concrete benchmark for judging the share price.

The report also listed LeMaitre's market capitalization at USD 1.81 billion on September 22, 2026. That value puts the company in the small-cap medical-device segment, where the share price can remain sensitive to earnings expectations even when the underlying business is specialized.

Specialized devices support demand

LeMaitre's product exposure is concentrated on vascular surgery rather than broad-based medical technology. According to StockStory on September 22, 2026, the company was founded in 1983 and manufactures devices used in the treatment of circulatory disease. The comparison between a USD 1.81 billion market value and a 25.8 forward P/E shows why operating growth remains important to the valuation.

For investors, the quantified relationship is straightforward: the forward earnings multiple is 25.8, while the equity value is USD 1.81 billion. Those two figures describe a company valued for continuing earnings rather than a distressed medical-device business, although they do not by themselves establish a future return.

LMAT stock stays at USD 79.13

LeMaitre Vascular stock stood at USD 79.13 on the Nasdaq on September 22, 2026. The closing level, the USD 1.81 billion market capitalization and the 25.8 forward P/E form the current reference points for the share.